The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer
Abstract
BACKGROUND: Pancreatic cancer, the fourth most common cause of cancer death in the United States, is hereditary in an estimated 10% of cases. Surveillance of patients with a familial predisposition for pancreatic cancer has not been systematically evaluated. OBJECTIVE: To develop a surveillance program that can identify and treat patients who have precancerous conditions of the pancreas and a family history of pancreatic cancer. DESIGN: Prospective cohort study. SETTING: University medical center. PATIENTS: 14 patients from three kindreds with a history of pancreatic cancer. INTERVENTIONS: Endoscopic ultrasonography, endoscopic retrograde cholangiopancreatography (ERCP), spiral computed tomography, and serum carcinoembryonic antigen and CA19-9 analysis were performed in all patients. Four affected patients were tested for the K-ras mutation. MAIN OUTCOME MEASUREMENT: Pancreatic dysplasia was determined by histologic evaluation. RESULTS: Seven of the 14 patients were believed to have dysplasia on the basis of clinical history and abnormalities on endoscopic ultrasonography and ERCP and were referred for pancreatectomy. All 7 patients had histologic evidence of dysplasia in pancreatectomy specimens. Findings on endoscopic ultrasonography were subtle, nonspecific, and similar to those seen in patients with chronic pancreatitis. Findings on ERCP ranged from mild and focal side-branch duct irregularities and small sacculations to main-duct strictures and grapelike clusters of saccules. Some of these changes are typical of chronic pancreatitis, but others are more distinctive. Spiral computed tomography and serum tumor markers had low sensitivity in the detection of pancreatic dysplasia. Analysis for the K-ras mutation yielded positive results in 3 of 4 patients with dysplasia. CONCLUSIONS: Thorough screening of patients with a family history of pancreatic cancer is feasible. Clinical data combined with imaging studies (endoscopic ultrasonography and ERCP) can be used to identify high-risk patients who have dysplasia. The role of molecular genetic testing is uncertain at this time.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The potential for early detection of asymptomatic pancreatic neoplasms in high-risk individuals (HRI) using an endoscopic approach was first reported in 1999 when the group at the University of Washington (Seattle, Wash) first reported the detection of “dysplasia” in 3 unusual familial pancreatic cancer (FPC) kindreds with multiple affected members.”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [73]
Citations
Cites
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1998) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.48.1.6 · Cited by 2,341
(2006) · Cancer · doi:10.1002/(issn)1097-0142 · Cited by 1,470
Warshaw, A. L., & Castillo, C. F.-D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202133260706 · Cited by 1,198
The Polyp-Cancer Sequence in the Large Bowel
Morson, B. (1974) · Proceedings of the Royal Society of Medicine · doi:10.1177/00359157740676p115 · Cited by 705 · cited 1×
“The time required for neoplastic progression clearly varies; however, it seems to be similar to the time required for tumor progression in other types of cancer, such as colonic carcinoma (17, 18).”
BackgroundCancer of the pancreas: 50 years of surgery
Gudjonsson, B. (1987) · Cancer · doi:10.1002/1097-0142(19871101)60:9<2284::aid-cncr2820600930>3.0.co;2-v · Cited by 616
Relation of pancreatic duct hyperplasia to carcinoma
Kozuka, S., Sassa, R., Taki, T., Masamoto, K., Nagasawa, S., Saga, S., Hasegawa, K., & Takeuchi, M. (1979) · Cancer · doi:10.1002/1097-0142(197904)43:4<1418::aid-cncr2820430431>3.0.co;2-o · Cited by 320
Progression of Pancreatic Intraductal Neoplasias to Infiltrating Adenocarcinoma of the Pancreas
Brat, D. J., Lillemoe, K. D., Yeo, C. J., Warfield, P. B., & Hruban, R. H. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199802000-00003 · Cited by 309 · cited 1×
“In a recent report (16), dysplasia was found incidentally in three patients who underwent partial pancreatic resection, all of whom subsequently developed cancer in the remaining pancreas within 1.”
BackgroundFamilial pancreatic cancer: a review.
Lynch, H. T., Smyrk, T. C., Kern, S. E., Hruban, R. H., Lightdale, C. J., Lemon, S. J., Lynch, J. F., Fusaro, L., Fusaro, R. M., & Ghadirian, P. (1996) · PubMed · Cited by 239
Kl�ppel, G., Bommer, G., R�ckert, K., & Seifert, G. (1980) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00430702 · Cited by 156
Brentnall, T. A., Chen, R., Lee, J. G., Kimmey, M. B., Bronner, M. P., Haggitt, R. C., Kowdley, K. V., Hecker, L. M., & Byrd, D. R. (1995) · PubMed · Cited by 154
Self-citation
Research works printed but not linked: 6
- Lynch HT, 1996, Semin Oncol, 23, 251
- Brentnall TA, 1995, Cancer Res, 55, 4264
- Barbosa JJ, 1946, Surg Gynecol Obstet, 82, 527
- Klimstra DS, 1994, Int J Pancreatol, 16, 224
- Pour P, 1977, Am J Pathol, 88, 291
- Morson BC, 1974, Proc R Soc Med, 67, 451
Cited by
Vincent, A., Herman, J., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,586
Li, D., Xie, K., Wolff, R., & Abbruzzese, J. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15841-8 · Cited by 1,719
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
Klein, A. P. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00457-x · Cited by 1,258
Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126
Progression model for pancreatic cancer.
Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 1,102
Metadata
- Authors
- Brentnall, T. A., Bronner, M. P., Byrd, D. R., Haggitt, R. C., & Kimmey, M. B.
- Affiliations
- University of Washington (US)
- Corresponding author
- Brentnall, Teresa A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1999-08-17
- Volume
- 131
- Issue
- 4
- Pages
- 247-255
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1974584607
- Semantic Scholar
- 26166a5d512d2a784257b95739581283dcb02531
- Cited by
- 391
- References
- 19
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 12 · 2022: 5 · 2021: 7 · 2020: 6 · 2019: 10 · 2018: 13 · 2017: 16 · 2016: 15 · 2015: 18 · 2014: 23 · 2013: 11 · 2012: 22
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic dysplasia, pancreatic cancer, familial pancreatic cancer, hereditary cancer predisposition, cancer surveillance, endoscopic ultrasound, endoscopic retrograde cholangiopancreatography, KRAS mutation, carcinoembryonic antigen, CA19-9, pancreatic resection, chronic pancreatitis
- MeSH terms
- Adult, Aged, Cholangiopancreatography, Endoscopic Retrograde, Female, Humans, Hyperplasia, Male, Middle Aged, Pancreas, Pancreatectomy, Pancreatic Neoplasms, Pedigree, Precancerous Conditions, Predictive Value of Tests, Prospective Studies, Tomography, X-Ray Computed, Biomarkers, Endosonography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer. https://app.cochat.ai/papers/10.7326/0003-4819-131-4-199908170-00003
- The paper
- Brentnall, T. A., Bronner, M. P., Byrd, D. R., Haggitt, R. C., & Kimmey, M. B. (1999). Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-131-4-199908170-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.